Author:
Melançon S.B.,Fontaine G.,Geoffroy G.,Vanasse M.,Dallaire L.,Potier M.
Abstract
SUMMARY:Serum lipoamide dehydrogenase activity and kinetics were studied in nine patients with Friedreich's ataxia before and three months after therapy with oral lecithin. Results disclosed a significant reduction in LAD inhibition by NADH in all patients after therapy. Three patients normalized their increased Km for lipoamide and one patient showed the opposite results after therapy. Two patients ceased lecithin after one month. All seven patients who remained in the trial group and one additional patient, showed subjective and objective signs of improvement in physical resistance. This study has offered some biochemical basis for the apparent clinical improvement in patients with Friedreich's ataxia who undergo lecithin therapy.
Publisher
Cambridge University Press (CUP)
Subject
Clinical Neurology,Neurology,General Medicine
Reference12 articles.
1. Lecithin consumption raises serum-free choline levels;Wurtman;Lancet,1977
2. Lipoamide dehydro-genase in serum: A preliminary report;Pelly;Clin. Chem,1976
3. Lipoamide dehydrogenase in cultured human skin fibroblasts
4. Lipoamide dehydrogenase in Friedreich’s Ataxia fibroblasts;Melançon;Can. J. Neurol. Sci,1978
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献